Nasal Obstruction and Olfactory Losses

Launched by OHIO STATE UNIVERSITY · Jun 16, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving symptoms related to nasal obstruction and smell loss, which affect about 30 million adults in the U.S. The researchers aim to create new tools that can better evaluate these symptoms, helping both patients and doctors make more informed decisions about treatment options. By participating in this study, individuals will have the opportunity to contribute to the development of these tools, potentially leading to better care for themselves and others with similar conditions.

To be eligible for this trial, participants should be experiencing problems with their sense of smell and have nasal obstruction. However, those with certain conditions, like congenital smell loss, nasal polyps, or previous head trauma, cannot participate. The trial is currently recruiting people aged between 18 and 75, and both men and women are welcome to join. If you decide to participate, you can expect to help researchers gain valuable insights into how to improve treatment for nasal and smell-related issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Smell Loss complaints
• • 2. Nasal Obstruction
• Exclusion Criteria:
• • 1. Congenital olfactory losses
• • 2. Nasal polyps, blocking the olfactory cleft
• • 3. Significant atrophy
• • 4. Cystic fibrosis
• • 5. Wegeners or any other connective tissue disorder
• • 6. Head trauma